Incorporating of herd immunity into pharmacoeconomic evaluation of pneumococcal conjugate vaccine PNC-7

被引：1
|
作者：
Claes, C
Reinert, RR
Schulenburg, JM
机构：
[1] Univ Hannover, Hannover, Germany
[2] Inst Med Microbiol, Aachen, Germany
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62761-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [1] Cost Effectiveness of Pneumococcal Vaccination for Infants and Children with the Conjugate Vaccine PnC-7 in Germany
    Christa Claes
    Johann-Matthias Graf von der Schulenburg
    [J]. PharmacoEconomics, 2003, 21 : 587 - 600
  • [2] Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in Germany
    Claes, C
    von der Schulenburg, JMG
    [J]. PHARMACOECONOMICS, 2003, 21 (08) : 587 - 600
  • [3] Pharmacoeconomic evaluation of herd protection for the seven-valent pneumococcal conjugate vaccine in Switzerland
    Ciuryla, VT
    Siegartel, LR
    Casciano, R
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 761 - 761
  • [4] A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada
    Lebel, MH
    Kellner, JD
    Ford-Jones, EL
    Hvidsten, K
    Wang, ECY
    Ciuryla, V
    Arikian, S
    Casciano, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (03) : 259 - 268
  • [5] Herd immunity and pneumococcal conjugate vaccine: A quantitative model
    Haber, Michael
    Barskey, Albert
    Baughman, Wendy
    Barker, Lawrence
    Whitney, Cynthia G.
    Shaw, Kate M.
    Orenstein, Walter
    Stephens, David S.
    [J]. VACCINE, 2007, 25 (29) : 5390 - 5398
  • [6] Pharmacoeconomic evaluation of herd immunity conferred by seven-valent pneumococcal conjugate vaccine (Prevnar®) in canada based on calgary region epidemiological data
    Casciano, R.
    Doyle, J.
    Kellner, J. D.
    Dolgitser, M.
    Stern, L.
    Krukas, M. R.
    Fontaine, L.
    Vicente, C.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A164 - A165
  • [7] A multinational pharmacoeconomic evaluation of direct and indirect immunity conferred by the seven-valent pneumococcal conjugate vaccine (PCV7)
    Strutton, D. R.
    Casciano, R.
    Stern, L.
    Doyle, J.
    Berenson, K.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A442 - A442
  • [8] A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain
    Asensi, F
    De Jose, M
    Lorente, M
    Moraga, F
    Ciuryla, V
    Arikian, S
    Casciano, R
    Vento, M
    [J]. VALUE IN HEALTH, 2004, 7 (01) : 36 - 51
  • [9] Cost effectiveness of adding 7-valent pneumococcal conjugate vaccine to a childhood vaccination - Impact of herd immunity
    Kristiansen, JS
    Wisloff, TF
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A154 - A155
  • [10] Herd immunity after pneumococcal conjugate vaccination
    Albrich, Werner C.
    Madhi, Shabir A.
    Lafond, Kathryn E.
    Klugman, Keith P.
    [J]. LANCET, 2007, 370 (9583): : 218 - 219
12345